Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
[DISCLOSURE] JW Pharmaceutical (001060) announced on Aug. 22 that it will issue redeemable convertible preferred stock worth 111.9 billion won (US$99.47 million) and offer to its largest stakeholder JW Holdings and four others, to raise capital.
JW Holdings will acquire stocks worth 68.9 billion won and increase its stake to 43.88 percent from 41.25 percent.
(theinvestor@heraldcorp.com)
JW Holdings will acquire stocks worth 68.9 billion won and increase its stake to 43.88 percent from 41.25 percent.
(theinvestor@heraldcorp.com)
